Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 211 for “"Polyglutamine"”.
-
Biological Consequences of Polyglutamine Repeats in Drosophila Muscle
Polyglutamine (polyQ) disease occurs by CAG repeat expansion, encoding a glutamine tract in the affected protein. Accumulation of these mutant polyQ proteins leads to formation of insoluble protein aggregates that impair many vital cellular processes. This manifests in neurodegenerative symptoms …
-
Experimental and Computational Analysis of Polyglutamine-Mediated Cytotoxicity
Expanded polyglutamine proteins are known to be the causative agents of a number of human neurodegenerative diseases but the molecular basis of their cytoxicity is still poorly understood. Polyglutamine tracts may impede the activity of the proteasome, and evidence from single cell imaging suggests …
-
The role of polyglutamine aggregate cytotoxicity in Huntington’s Disease
<p>Polyglutamine diseases refer to a group of neuro-degenerative diseases including Huntington's disease , that share the same mutational basis: expansion of a CAG repeat coding sequence that encodes for a polyglutamine repeat in the respective proteins. Neuronal intranuclear inclusions (NII) …
-
Creation of model proteins to investigate the mechanism of aggregation of expanded-polyglutamine proteins. Insertion of polyglutamine tracts into the ß-lactamase BlaP
Polyglutamine (polyQ) diseases are characterized by the formation of intranuclear amyloid-like aggregates by proteins containing an expansion of a polyQ tract above a threshold length. These insoluble aggregates and/or some of their soluble precursors are thought to play a role in the pathogenesis …
-
Unzipping the Polyglutamine Steric Zipper Using High Throughput Flow Cytometry
… of this lack of sequence complexity is the polyglutamine expansion underlying Huntingtin’s Disease (HD). We utilized a high-throughput cytometric platform for the analysis of amyloid nucleation barriers in living cells to systematically dissect the nucleus of polyglutamine expansions. We …
-
Probing the Early Stages of Polyglutamine Aggregation with Computational Methods
… carry expanded stretches of glutamine residues: polyglutamine). The length of the polyglutamine segment is inversely correlated with the disease age-of-onset. Protein aggregates are routinely found in postmortem tissue samples of brains of HD patients. These findings suggest a prominent role for …
-
Polyglutamine monomer structure and its implications for molecular self-assembly
Polyglutamine is a naturally occurring peptide found within several proteins in neuronal cells of the brain, and its aggregation has been implicated in several neurodegenerative diseases, including Huntington's disease. The resulting aggregates have been demonstrated to possess ~-sheet structure, …
-
Polyglutamine-mediated and heavy metal-induced transcription from yeast to humans
… two major projects, namely, the effect of polyglutamine tracts on the activity of a specific transcription factor, and on regulation of heavy metal homeostasis and detoxification. Project I: Many proteins, especially regulatory proteins of gene expression, contain homopolymeric repeats of …
-
Regulation of the redox homeostasis during polyglutamine misfolding in Huntington’s Disease
… several cellular models of intracellular polyglutamine (polyQ) protein misfolding were established for mechanistic studies.<br/><br/>Various in vitro transient and stable cell expression systems expressing an N-terminal fragment of huntingtin (htt) (httExon 1, httEx1) with/or without a …
-
Studies of genetic factors modulating polyglutamine toxicity in the yeast model
Polyglutamine-expanded fragments, derived from the human huntingtin protein, are aggregation-prone and toxic in yeast cells, bearing endogenous QN-rich proteins in the aggregated (prion) form. Attachment of the proline-rich region targets polyglutamine aggregates to the large perinuclear deposit …
-
Investigation of the pathogenic agent in a Drosophila model of polyglutamine disease
… body of evidence supports the identity of polyglutamine as the pathogenic agent in a variety of human neurodegenerative diseases (some of which are clinically indistinguishable from the polyglutamine diseases) that are due to expanded repeats that cannot encode polyglutamine. As …
-
Genomic characterization of human traits associated with polyglutamine disease genes and modifiers
Background: Polyglutamine (polyQ) diseases, such as Huntington disease (HD) and certain spinocerebellar ataxia, are a group of severe neurodegenerative disorders caused by duplication of the glutamine codon. These conditions currently lack effective treatments, and most therapeutics in development …
-
Structural study of polyglutamine and molecular mechanism of toll-like receptor signaling
… by the expansion of a CAG repeats encoding polyglutamine (polyQ) in the first exon of Huntingtin (Htt) gene. In HD patients, polyQ contains 36-183 glutamine residues, whereas normal individuals have a polyQ of only 8-35 residues. To elucidate this threshold phenomenon of polyQ aggregation, …
-
Interactions between endogenous prions, chaperones and polyglutamine proteins in the yeast model
Poly-Q expanded exon 1 of huntingtin (Q103) fused to GFP is toxic to yeast cells containing endogenous yeast prions, [PIN+] ([RNQ+]) and/or [PSI+], which presumably serve as aggregation nuclei. Propagation of yeast prions is modulated by the chaperones of Hsp100/70/40 complex. While some chaperones …
-
Developing the Yeast Disaggregase Hsp104 as a Treatment for Polyglutamine Disease in Drosophila
… protein fragment containing an expanded polyglutamine tract. However, we found that Hsp104 worsened toxicity of the full-length pathogenic polyglutamine protein, and this coincided with increased accumulation of amyloid inclusions. This aberrant activity of Hsp104 depended on intact …
-
Degradation Of The Huntingtin Polyglutamine Domain By The Proteasome: Implication To Huntington’s Disease
… mutation that leads to an abnormally expanded polyglutamine (PolyQ) sequence within the protein. The disease is characterized by the accumulation of ubiquitinated mutant htt, suggesting dysfunction of the ubiquitin-proteasome system. Interestingly, there is data suggesting that the proteasome …
-
The Influence Of Protein Context On Polyglutamine Toxicity In Spinocerebellar Ataxia Type 3
The polyglutamine (polyQ) disease family is composed of nine neurodegenerative diseases caused by CAG trinucleotide repeat expansions in the associated genes. Although these diseases are caused by similar mutations, the polyQ proteins are otherwise structurally and functionally unique. Thus, the …
-
ANDROGEN RECEPTOR POLYGLUTAMINE REPEAT LENGTH AFFECTS RECEPTOR ACTIVITY AND C2C12 CELL MYOGENIC POTENTIAL
… progression. <italic>Conclusion:</italic> AR polyglutamine repeat length affects receptor activity and alters the growth and development of C2C12 cells. This polymorphism may explain some of the heritability of muscle mass in humans.
Page 1 of 11